Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis.
about
Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells.Phospholipase A2 mediates apolipoprotein-independent uptake of chylomicron remnant-like particles by human macrophages.In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.Biallelic mutations in PLA2G5, encoding group V phospholipase A2, cause benign fleck retinaAMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species.Role of secretory phospholipases in atherogenesis.Synthesis of 2-oxoamides based on sulfonamide analogs of gamma-amino acids and their activity on phospholipase A2.Molecular and functional characterization of polymorphisms in the secreted phospholipase A2 group X gene: relevance to coronary artery diseaseGeneration in human plasma of misfolded, aggregation-prone electronegative low density lipoprotein.Biology of secretory phospholipase A2.Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymesPhospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases.Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosisA snake venom group IIA PLA2 with immunomodulatory activity induces formation of lipid droplets containing 15-d-PGJ2 in macrophages.Alterations of specific lipid groups in serum of obese humans: a review.Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer.Phase composition of lipoprotein SM/cholesterol/PtdCho affects FA specificity of sPLA2s.
P2860
Q33987854-6C8540CE-2D85-4ED0-8FD4-310C09B569D6Q35176691-F3BEA56C-774A-4DE1-B5F3-EF92EF80FE68Q35590666-3C4D0D8E-2511-4C07-9978-744C855DFBA7Q35603281-F857C86B-B8F3-49C9-95B0-0472681EAF32Q35688331-1BEC777C-211F-4DC6-A822-6C0DB9749D45Q36493893-E5AF2C6C-1A4B-4B59-BF7C-3B71058429C1Q37167790-E4717538-FD14-4976-9E4C-2453ED2F4320Q37184050-8CD60AE3-6122-4ABE-B1BE-E7906F340AF1Q37238669-EA457171-52E3-4DAF-B7F4-3E839DB7DA63Q37263281-AEB774F2-38C3-4AB5-A932-A209DF25D4EAQ37293299-146ACBCD-2BD8-44DF-9DA8-7A479C21FCDCQ37485758-C8379B2A-6F8C-423A-A750-FB38BF01B8AAQ37658843-3284AB9F-8366-4256-B994-F93630FD0649Q37683292-E0B3CB6E-76D6-4BFF-8302-F1D3E48590EBQ38712999-2EFF91C5-BA07-45B7-BD0B-6AB71BD17D26Q39023727-877AE36A-501D-4198-8DF6-EE8EE32187BCQ39136980-23BF3E9A-3365-4ABA-B11C-574C2CE53E91Q39297921-D9FB2736-99E0-4D01-AB18-12A36DB056B9Q46512954-9B199EF2-79A3-4B1F-88E8-E05FAA64276F
P2860
Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Distinctiveness of secretory p ...... ique roles in atherosclerosis.
@ast
Distinctiveness of secretory p ...... ique roles in atherosclerosis.
@en
type
label
Distinctiveness of secretory p ...... ique roles in atherosclerosis.
@ast
Distinctiveness of secretory p ...... ique roles in atherosclerosis.
@en
prefLabel
Distinctiveness of secretory p ...... ique roles in atherosclerosis.
@ast
Distinctiveness of secretory p ...... ique roles in atherosclerosis.
@en
P2093
P1476
Distinctiveness of secretory p ...... ique roles in atherosclerosis.
@en
P2093
Ann-Cathrine Jönsson-Rylander
Birgitta Rosengren
Eva Hurt-Camejo
German Camejo
Helena Peilot
P304
P356
10.1016/J.BBALIP.2006.06.008
P407
P577
2006-07-08T00:00:00Z